Table of Content

1 Angiotensin II Receptor Blockers Market Overview
1.1 Angiotensin II Receptor Blockers Product Scope
1.2 Angiotensin II Receptor Blockers Segment by Type
1.2.1 Global Angiotensin II Receptor Blockers Sales by Type (2016 & 2021 & 2027)
1.2.2 Azilsartan
1.2.3 Candesartan
1.2.4 Eprosartan
1.2.5 Irbesartan
1.2.6 Losartan
1.2.7 Olmesartan
1.2.8 Telmisartan
1.2.9 Valsartan
1.3 Angiotensin II Receptor Blockers Segment by Application
1.3.1 Global Angiotensin II Receptor Blockers Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Chronic Kidney Diseases
1.3.3 Heart Failure
1.3.4 Kidney Failure in Diabetes
1.4 Angiotensin II Receptor Blockers Market Estimates and Forecasts (2016-2027)
1.4.1 Global Angiotensin II Receptor Blockers Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Angiotensin II Receptor Blockers Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Angiotensin II Receptor Blockers Price Trends (2016-2027)

2 Angiotensin II Receptor Blockers Estimates and Forecasts by Region
2.1 Global Angiotensin II Receptor Blockers Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Angiotensin II Receptor Blockers Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Angiotensin II Receptor Blockers Sales Market Share by Region (2016-2021)
2.2.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2016-2021)
2.3 Global Angiotensin II Receptor Blockers Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Angiotensin II Receptor Blockers Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Angiotensin II Receptor Blockers Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Angiotensin II Receptor Blockers Estimates and Projections (2016-2027)
2.4.2 Europe Angiotensin II Receptor Blockers Estimates and Projections (2016-2027)
2.4.3 China Angiotensin II Receptor Blockers Estimates and Projections (2016-2027)
2.4.4 Japan Angiotensin II Receptor Blockers Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Angiotensin II Receptor Blockers Estimates and Projections (2016-2027)
2.4.6 India Angiotensin II Receptor Blockers Estimates and Projections (2016-2027)
3 Global Angiotensin II Receptor Blockers Competition Landscape by Players
3.1 Global Top Angiotensin II Receptor Blockers Players by Sales (2016-2021)
3.2 Global Top Angiotensin II Receptor Blockers Players by Revenue (2016-2021)
3.3 Global Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiotensin II Receptor Blockers as of 2020)
3.4 Global Angiotensin II Receptor Blockers Average Price by Company (2016-2021)
3.5 Manufacturers Angiotensin II Receptor Blockers Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Angiotensin II Receptor Blockers Market Size by Type
4.1 Global Angiotensin II Receptor Blockers Historic Market Review by Type (2016-2021)
4.1.1 Global Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021)
4.1.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Type (2016-2021)
4.1.3 Global Angiotensin II Receptor Blockers Price by Type (2016-2021)
4.2 Global Angiotensin II Receptor Blockers Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Angiotensin II Receptor Blockers Sales Forecast by Type (2022-2027)
4.2.2 Global Angiotensin II Receptor Blockers Revenue Forecast by Type (2022-2027)
4.2.3 Global Angiotensin II Receptor Blockers Price Forecast by Type (2022-2027)
5 Global Angiotensin II Receptor Blockers Market Size by Application
5.1 Global Angiotensin II Receptor Blockers Historic Market Review by Application (2016-2021)
5.1.1 Global Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021)
5.1.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Application (2016-2021)
5.1.3 Global Angiotensin II Receptor Blockers Price by Application (2016-2021)
5.2 Global Angiotensin II Receptor Blockers Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Angiotensin II Receptor Blockers Sales Forecast by Application (2022-2027)
5.2.2 Global Angiotensin II Receptor Blockers Revenue Forecast by Application (2022-2027)
5.2.3 Global Angiotensin II Receptor Blockers Price Forecast by Application (2022-2027)

6 North America Angiotensin II Receptor Blockers Market Facts & Figures
6.1 North America Angiotensin II Receptor Blockers Sales by Company
6.1.1 North America Angiotensin II Receptor Blockers Sales by Company (2016-2021)
6.1.2 North America Angiotensin II Receptor Blockers Revenue by Company (2016-2021)
6.2 North America Angiotensin II Receptor Blockers Sales Breakdown by Type
6.2.1 North America Angiotensin II Receptor Blockers Sales Breakdown by Type (2016-2021)
6.2.2 North America Angiotensin II Receptor Blockers Sales Breakdown by Type (2022-2027)
6.3 North America Angiotensin II Receptor Blockers Sales Breakdown by Application
6.3.1 North America Angiotensin II Receptor Blockers Sales Breakdown by Application (2016-2021)
6.3.2 North America Angiotensin II Receptor Blockers Sales Breakdown by Application (2022-2027)

7 Europe Angiotensin II Receptor Blockers Market Facts & Figures
7.1 Europe Angiotensin II Receptor Blockers Sales by Company
7.1.1 Europe Angiotensin II Receptor Blockers Sales by Company (2016-2021)
7.1.2 Europe Angiotensin II Receptor Blockers Revenue by Company (2016-2021)
7.2 Europe Angiotensin II Receptor Blockers Sales Breakdown by Type
7.2.1 Europe Angiotensin II Receptor Blockers Sales Breakdown by Type (2016-2021)
7.2.2 Europe Angiotensin II Receptor Blockers Sales Breakdown by Type (2022-2027)
7.3 Europe Angiotensin II Receptor Blockers Sales Breakdown by Application
7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Angiotensin II Receptor Blockers Market Facts & Figures
8.1 China Angiotensin II Receptor Blockers Sales by Company
8.1.1 China Angiotensin II Receptor Blockers Sales by Company (2016-2021)
8.1.2 China Angiotensin II Receptor Blockers Revenue by Company (2016-2021)
8.2 China Angiotensin II Receptor Blockers Sales Breakdown by Type
8.2.1 China Angiotensin II Receptor Blockers Sales Breakdown by Type (2016-2021)
8.2.2 China Angiotensin II Receptor Blockers Sales Breakdown by Type (2022-2027)
8.3 China Angiotensin II Receptor Blockers Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Angiotensin II Receptor Blockers Market Facts & Figures
9.1 Japan Angiotensin II Receptor Blockers Sales by Company
9.1.1 Japan Angiotensin II Receptor Blockers Sales by Company (2016-2021)
9.1.2 Japan Angiotensin II Receptor Blockers Revenue by Company (2016-2021)
9.2 Japan Angiotensin II Receptor Blockers Sales Breakdown by Type
9.2.1 Japan Angiotensin II Receptor Blockers Sales Breakdown by Type (2016-2021)
9.2.2 Japan Angiotensin II Receptor Blockers Sales Breakdown by Type (2022-2027)
9.3 Japan Angiotensin II Receptor Blockers Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Angiotensin II Receptor Blockers Market Facts & Figures
10.1 Southeast Asia Angiotensin II Receptor Blockers Sales by Company
10.1.1 Southeast Asia Angiotensin II Receptor Blockers Sales by Company (2016-2021)
10.1.2 Southeast Asia Angiotensin II Receptor Blockers Revenue by Company (2016-2021)
10.2 Southeast Asia Angiotensin II Receptor Blockers Sales Breakdown by Type
10.2.1 Southeast Asia Angiotensin II Receptor Blockers Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Angiotensin II Receptor Blockers Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Angiotensin II Receptor Blockers Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Angiotensin II Receptor Blockers Market Facts & Figures
11.1 India Angiotensin II Receptor Blockers Sales by Company
11.1.1 India Angiotensin II Receptor Blockers Sales by Company (2016-2021)
11.1.2 India Angiotensin II Receptor Blockers Revenue by Company (2016-2021)
11.2 India Angiotensin II Receptor Blockers Sales Breakdown by Type
11.2.1 India Angiotensin II Receptor Blockers Sales Breakdown by Type (2016-2021)
11.2.2 India Angiotensin II Receptor Blockers Sales Breakdown by Type (2022-2027)
11.3 India Angiotensin II Receptor Blockers Sales Breakdown by Application
11.3.1 India Angiotensin II Receptor Blockers Sales Breakdown by Application (2016-2021)
11.3.2 India Angiotensin II Receptor Blockers Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Angiotensin II Receptor Blockers Business
12.1 Merck & Co.
12.1.1 Merck & Co. Corporation Information
12.1.2 Merck & Co. Business Overview
12.1.3 Merck & Co. Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck & Co. Angiotensin II Receptor Blockers Products Offered
12.1.5 Merck & Co. Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Angiotensin II Receptor Blockers Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Angiotensin II Receptor Blockers Products Offered
12.3.5 Novartis Recent Development
12.4 Teva
12.4.1 Teva Corporation Information
12.4.2 Teva Business Overview
12.4.3 Teva Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Teva Angiotensin II Receptor Blockers Products Offered
12.4.5 Teva Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Business Overview
12.5.3 Bayer Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Angiotensin II Receptor Blockers Products Offered
12.5.5 Bayer Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Corporation Information
12.6.2 GlaxoSmithKline Business Overview
12.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Products Offered
12.6.5 GlaxoSmithKline Recent Development
12.7 Sun Pharmaceutical
12.7.1 Sun Pharmaceutical Corporation Information
12.7.2 Sun Pharmaceutical Business Overview
12.7.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Products Offered
12.7.5 Sun Pharmaceutical Recent Development
12.8 Mylan
12.8.1 Mylan Corporation Information
12.8.2 Mylan Business Overview
12.8.3 Mylan Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Mylan Angiotensin II Receptor Blockers Products Offered
12.8.5 Mylan Recent Development

13 Angiotensin II Receptor Blockers Manufacturing Cost Analysis
13.1 Angiotensin II Receptor Blockers Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Angiotensin II Receptor Blockers
13.4 Angiotensin II Receptor Blockers Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Angiotensin II Receptor Blockers Distributors List
14.3 Angiotensin II Receptor Blockers Customers

15 Market Dynamics
15.1 Angiotensin II Receptor Blockers Market Trends
15.2 Angiotensin II Receptor Blockers Drivers
15.3 Angiotensin II Receptor Blockers Market Challenges
15.4 Angiotensin II Receptor Blockers Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Angiotensin II Receptor Blockers Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Angiotensin II Receptor Blockers Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Angiotensin II Receptor Blockers Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Angiotensin II Receptor Blockers Sales (K Units) by Region (2016-2021)
Table 5. Global Angiotensin II Receptor Blockers Sales Market Share by Region (2016-2021)
Table 6. Global Angiotensin II Receptor Blockers Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Angiotensin II Receptor Blockers Revenue Share by Region (2016-2021)
Table 8. Global Angiotensin II Receptor Blockers Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Angiotensin II Receptor Blockers Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Angiotensin II Receptor Blockers Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Angiotensin II Receptor Blockers Revenue Share Forecast by Region (2022-2027)
Table 12. Global Angiotensin II Receptor Blockers Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Angiotensin II Receptor Blockers Sales Share by Company (2016-2021)
Table 14. Global Angiotensin II Receptor Blockers Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Angiotensin II Receptor Blockers Revenue Share by Company (2016-2021)
Table 16. Global Angiotensin II Receptor Blockers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin II Receptor Blockers as of 2020)
Table 17. Global Angiotensin II Receptor Blockers Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Angiotensin II Receptor Blockers Manufacturing Sites and Area Served
Table 19. Manufacturers Angiotensin II Receptor Blockers Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Angiotensin II Receptor Blockers Sales (K Units) by Type (2016-2021)
Table 22. Global Angiotensin II Receptor Blockers Sales Share by Type (2016-2021)
Table 23. Global Angiotensin II Receptor Blockers Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Type (2016-2021)
Table 25. Global Angiotensin II Receptor Blockers Sales Share by Type (2022-2027)
Table 26. Global Angiotensin II Receptor Blockers Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Angiotensin II Receptor Blockers Revenue Share by Type (2022-2027)
Table 28. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Type (2022-2027)
Table 29. Global Angiotensin II Receptor Blockers Sales (K Units) by Application (2016-2021)
Table 30. Global Angiotensin II Receptor Blockers Sales Share by Application (2016-2021)
Table 31. Global Angiotensin II Receptor Blockers Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Application (2016-2021)
Table 33. Global Angiotensin II Receptor Blockers Sales (K Units) by Application (2022-2027)
Table 34. Global Angiotensin II Receptor Blockers Sales Share by Application (2022-2027)
Table 35. Global Angiotensin II Receptor Blockers Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Angiotensin II Receptor Blockers Revenue Share by Application (2022-2027)
Table 37. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Application (2022-2027)
Table 38. North America Angiotensin II Receptor Blockers Sales (K Units) by Company (2016-2021)
Table 39. North America Angiotensin II Receptor Blockers Sales Market Share by Company (2016-2021)
Table 40. North America Angiotensin II Receptor Blockers Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Angiotensin II Receptor Blockers Revenue Market Share by Company (2016-2021)
Table 42. North America Angiotensin II Receptor Blockers Sales by Type (2016-2021) & (K Units)
Table 43. North America Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021)
Table 44. North America Angiotensin II Receptor Blockers Sales by Type (2022-2027) & (K Units)
Table 45. North America Angiotensin II Receptor Blockers Sales Market Share by Type (2022-2027)
Table 46. North America Angiotensin II Receptor Blockers Sales by Application (2016-2021) & (K Units)
Table 47. North America Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021)
Table 48. North America Angiotensin II Receptor Blockers Sales by Application (2022-2027) & (K Units)
Table 49. North America Angiotensin II Receptor Blockers Sales Market Share by Application (2022-2027)
Table 50. Europe Angiotensin II Receptor Blockers Sales (K Units) by Company (2016-2021)
Table 51. Europe Angiotensin II Receptor Blockers Sales Market Share by Company (2016-2021)
Table 52. Europe Angiotensin II Receptor Blockers Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Angiotensin II Receptor Blockers Revenue Market Share by Company (2016-2021)
Table 54. Europe Angiotensin II Receptor Blockers Sales by Type (2016-2021) & (K Units)
Table 55. Europe Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021)
Table 56. Europe Angiotensin II Receptor Blockers Sales by Type (2022-2027) & (K Units)
Table 57. Europe Angiotensin II Receptor Blockers Sales Market Share by Type (2022-2027)
Table 58. Europe Angiotensin II Receptor Blockers Sales by Application (2016-2021) & (K Units)
Table 59. Europe Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021)
Table 60. Europe Angiotensin II Receptor Blockers Sales by Application (2022-2027) & (K Units)
Table 61. Europe Angiotensin II Receptor Blockers Sales Market Share by Application (2022-2027)
Table 62. China Angiotensin II Receptor Blockers Sales (K Units) by Company (2016-2021)
Table 63. China Angiotensin II Receptor Blockers Sales Market Share by Company (2016-2021)
Table 64. China Angiotensin II Receptor Blockers Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Angiotensin II Receptor Blockers Revenue Market Share by Company (2016-2021)
Table 66. China Angiotensin II Receptor Blockers Sales by Type (2016-2021) & (K Units)
Table 67. China Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021)
Table 68. China Angiotensin II Receptor Blockers Sales by Type (2022-2027) & (K Units)
Table 69. China Angiotensin II Receptor Blockers Sales Market Share by Type (2022-2027)
Table 70. China Angiotensin II Receptor Blockers Sales by Application (2016-2021) & (K Units)
Table 71. China Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021)
Table 72. China Angiotensin II Receptor Blockers Sales by Application (2022-2027) & (K Units)
Table 73. China Angiotensin II Receptor Blockers Sales Market Share by Application (2022-2027)
Table 74. Japan Angiotensin II Receptor Blockers Sales (K Units) by Company (2016-2021)
Table 75. Japan Angiotensin II Receptor Blockers Sales Market Share by Company (2016-2021)
Table 76. Japan Angiotensin II Receptor Blockers Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Angiotensin II Receptor Blockers Revenue Market Share by Company (2016-2021)
Table 78. Japan Angiotensin II Receptor Blockers Sales by Type (2016-2021) & (K Units)
Table 79. Japan Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021)
Table 80. Japan Angiotensin II Receptor Blockers Sales by Type (2022-2027) & (K Units)
Table 81. Japan Angiotensin II Receptor Blockers Sales Market Share by Type (2022-2027)
Table 82. Japan Angiotensin II Receptor Blockers Sales by Application (2016-2021) & (K Units)
Table 83. Japan Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021)
Table 84. Japan Angiotensin II Receptor Blockers Sales by Application (2022-2027) & (K Units)
Table 85. Japan Angiotensin II Receptor Blockers Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Angiotensin II Receptor Blockers Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Angiotensin II Receptor Blockers Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Angiotensin II Receptor Blockers Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Angiotensin II Receptor Blockers Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Angiotensin II Receptor Blockers Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Angiotensin II Receptor Blockers Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Angiotensin II Receptor Blockers Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Angiotensin II Receptor Blockers Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Angiotensin II Receptor Blockers Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Angiotensin II Receptor Blockers Sales Market Share by Application (2022-2027)
Table 98. India Angiotensin II Receptor Blockers Sales (K Units) by Company (2016-2021)
Table 99. India Angiotensin II Receptor Blockers Sales Market Share by Company (2016-2021)
Table 100. India Angiotensin II Receptor Blockers Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Angiotensin II Receptor Blockers Revenue Market Share by Company (2016-2021)
Table 102. India Angiotensin II Receptor Blockers Sales by Type (2016-2021) & (K Units)
Table 103. India Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021)
Table 104. India Angiotensin II Receptor Blockers Sales by Type (2022-2027) & (K Units)
Table 105. India Angiotensin II Receptor Blockers Sales Market Share by Type (2022-2027)
Table 106. India Angiotensin II Receptor Blockers Sales by Application (2016-2021) & (K Units)
Table 107. India Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021)
Table 108. India Angiotensin II Receptor Blockers Sales by Application (2022-2027) & (K Units)
Table 109. India Angiotensin II Receptor Blockers Sales Market Share by Application (2022-2027)
Table 110. Merck & Co. Corporation Information
Table 111. Merck & Co. Description and Business Overview
Table 112. Merck & Co. Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Merck & Co. Angiotensin II Receptor Blockers Product
Table 114. Merck & Co. Recent Development
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. AstraZeneca Angiotensin II Receptor Blockers Product
Table 119. AstraZeneca Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Novartis Angiotensin II Receptor Blockers Product
Table 124. Novartis Recent Development
Table 125. Teva Corporation Information
Table 126. Teva Description and Business Overview
Table 127. Teva Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Teva Angiotensin II Receptor Blockers Product
Table 129. Teva Recent Development
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Business Overview
Table 132. Bayer Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Bayer Angiotensin II Receptor Blockers Product
Table 134. Bayer Recent Development
Table 135. GlaxoSmithKline Corporation Information
Table 136. GlaxoSmithKline Description and Business Overview
Table 137. GlaxoSmithKline Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. GlaxoSmithKline Angiotensin II Receptor Blockers Product
Table 139. GlaxoSmithKline Recent Development
Table 140. Sun Pharmaceutical Corporation Information
Table 141. Sun Pharmaceutical Description and Business Overview
Table 142. Sun Pharmaceutical Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Sun Pharmaceutical Angiotensin II Receptor Blockers Product
Table 144. Sun Pharmaceutical Recent Development
Table 145. Mylan Corporation Information
Table 146. Mylan Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Mylan Description and Business Overview
Table 148. Mylan Angiotensin II Receptor Blockers Product
Table 149. Mylan Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Angiotensin II Receptor Blockers Distributors List
Table 153. Angiotensin II Receptor Blockers Customers List
Table 154. Angiotensin II Receptor Blockers Market Trends
Table 155. Angiotensin II Receptor Blockers Market Drivers
Table 156. Angiotensin II Receptor Blockers Market Challenges
Table 157. Angiotensin II Receptor Blockers Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin II Receptor Blockers Product Picture
Figure 2. Global Angiotensin II Receptor Blockers Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Angiotensin II Receptor Blockers Sales Market Share by Application in 2021 & 2027
Figure 6. Chronic Kidney Diseases Examples
Figure 7. Heart Failure Examples
Figure 8. Kidney Failure in Diabetes Examples
Figure 9. Global Angiotensin II Receptor Blockers Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Angiotensin II Receptor Blockers Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Angiotensin II Receptor Blockers Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Angiotensin II Receptor Blockers Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Angiotensin II Receptor Blockers Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Angiotensin II Receptor Blockers Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Angiotensin II Receptor Blockers Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Angiotensin II Receptor Blockers Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Angiotensin II Receptor Blockers Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Angiotensin II Receptor Blockers Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Angiotensin II Receptor Blockers Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Angiotensin II Receptor Blockers Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Angiotensin II Receptor Blockers Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Angiotensin II Receptor Blockers Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Angiotensin II Receptor Blockers Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Angiotensin II Receptor Blockers Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Angiotensin II Receptor Blockers Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Angiotensin II Receptor Blockers Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Angiotensin II Receptor Blockers Players Market Share by Revenue in Angiotensin II Receptor Blockers: 2016 & 2020
Figure 28. Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Angiotensin II Receptor Blockers Revenue Share by Type (2016-2021)
Figure 30. Global Angiotensin II Receptor Blockers Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Angiotensin II Receptor Blockers Revenue Share by Application (2016-2021)
Figure 32. Global Angiotensin II Receptor Blockers Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Angiotensin II Receptor Blockers Sales Market Share by Type in 2020
Figure 34. North America Angiotensin II Receptor Blockers Sales Market Share by Application in 2020
Figure 35. Europe Angiotensin II Receptor Blockers Sales Market Share by Type in 2020
Figure 36. Europe Angiotensin II Receptor Blockers Sales Market Share by Application in 2020
Figure 37. China Angiotensin II Receptor Blockers Sales Market Share by Type in 2020
Figure 38. China Angiotensin II Receptor Blockers Sales Market Share by Application in 2020
Figure 39. Japan Angiotensin II Receptor Blockers Sales Market Share by Type in 2020
Figure 40. Japan Angiotensin II Receptor Blockers Sales Market Share by Application in 2020
Figure 41. Southeast Asia Angiotensin II Receptor Blockers Sales Market Share by Type in 2020
Figure 42. Southeast Asia Angiotensin II Receptor Blockers Sales Market Share by Application in 2020
Figure 43. India Angiotensin II Receptor Blockers Sales Market Share by Type in 2020
Figure 44. India Angiotensin II Receptor Blockers Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Angiotensin II Receptor Blockers
Figure 47. Manufacturing Process Analysis of Angiotensin II Receptor Blockers
Figure 48. Angiotensin II Receptor Blockers Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed